2025 winners

Junior Research Grant

Maria Jassinskaja, Lund University, Sweden

Topic: Rejuvenating aged hematopoiesis via modulation of the bone marrow niche

Vanessa Katia Favasuli, Candiolo Cancer Institute, Fondazione del Piemonte per l’Oncologia, Italy

Topic: Decoding the biologic and therapeutic roles of lncRNAs in multiple myeloma

Srdjan Grusanovic, Institute of Molecular Genetics of the Czech Academy of Sciences, Czechia

Topic: Effects of chronic inflammation on hematopoietic stem cell aging and response to infection

Advanced Research Grant

Nisha Narayan, University of Cambridge, United Kingdom

Topic: Clonal tracing to assess leukaemia stem cell heterogeneity and mechanisms of therapy resistance in acute myeloid leukaemia

Anastasia Conti, Fondazione Telethon ETS, Italy

Topic: Transposable element reactivation in Acute Myeloid Leukemia: functional relevance to therapy response and relapse

Heidi Neubauer, University of Veterinary Medicine Vienna, Austria

Topic: The mechanisms of STAT5B sex-specific functions in hematopoiesis

Physician Scientist Research Grant

Anjum Khan, University of York, United Kingdom

Topic: Targeting proteostatic vulnerabilities in leukaemic stem cells

Anjali Cremer, Goethe University Hospital Frankfurt, Germany

Topic: Mechanisms of response and resistance to CD38 blocking in adult R/R T-ALL

Tomas Jelinek, University of Ostrava, Czechia

Topic: Tumor microenvironment and clonal evolution in myeloma extramedullary disease

Topics-in-Focus Advanced Research Grant

Megane Brusson, Imagine Institute, France

Topic: Identifying novel therapeutic targets for beta-hemoglobinopathies using single-cell RNA sequencing and knock-out CRISPR-Cas9 screening

Michela Milani, Fondazione Telethon ETS, Italy

Topic: LV-mediated in vivo platelet gene therapy for hemophilia A

Pedro Moura, Karolinska Institutet, Sweden

Topic: Leveraging recurrent neoantigen generation against SF3B1-mutated myelodysplastic syndromes

Topics-in-Focus Physician Scientist Research Grant

Minke Rab, Erasmus University Medical Center, The Netherlands

Topic: Red blood cell dehydration in HbSC disease: peril or promise

Bilateral Collaborative Grant

Lorenzo Brunetti, Università Politecnica delle Marche, Italy

Hannah Uckelmann, University Clinic Frankfurt, Germany

Topic: Deciphering the cellular and molecular impact of XPO1 inhibition in NPM1-mutated AML patients

Simona Valletta, University of Manchester, United Kingdom

Jolanda Sarno, Tettamanti Research Center, Italy

Topic: Understanding how AML interacts with the immune system through CCR1 signalling pathway: a step toward the development of novel immunotherapeutic approaches

Jessica Nordlund, Uppsala University, Sweden

Merja Heinäniemi, University of Eastern Finland, Finland

Topic: Dynamics of acute lymphoblastic leukemia revealed by spatial proteomics

Kick-Off Grant

Anna Marneth, Radboud University Medical Centre, The Netherlands

Topic: Restoring Immunogenic Dendritic Cell Function via Glycan Targeting in AML

Martí Farrera-Sal, Vall d'Hebron Institute of Oncology, Spain

Topic: CARtun Platform: fine-tuning Chimeric Antigen Receptor design to enhance CAR T-cell therapy across hematological malignancies

Emilio Manuel Serrano López, Mediterranean Centre for Molecular Medicine (C3M), France

Topic: TET2-MAP: Decoding the TET2 interactome in mature B-cell lymphomas

Diana Gulei Tomuleasa, Iuliu Hatieganu University of Medicine and Pharmacy, Romania

Topic: The potential role of N6-methyladenosine compensation in myeloid neoplasms resistant to demethylating agents targeted against cytosine modifications

Frank Y. Huang, German Cancer Research Center, Germany

Topic: Decoding the Consequences of Whole Genome Doubling in Acute Myeloid Leukemia

Research Mobility Grant

Esther Prados de la Torre, University of Córdoba, Spain

Topic: Immunopeptidome analysis in AML

Marco Maria Sindoni, University of Milano-Bicocca, Italy

Topic: Spectral Pipeline for Efficient Cytometric High-Throughput Analysis

Aimilia Vareli, Brighton and Sussex Medical School, United Kingdom

Topic: Disentangling NF-κΒ and BCL2 in Diffuse Large B-cell Lymphoma

Emanuele Sclarandi, Università degli Studi di Milano, Italy

Topic: Machine Learning to Infer the Presence of Mosaic Chromosomal Alterations from Blood Count Data

Léa Dehgane, Centre de Recherche des Cordeliers, France

Topic: Treatment resistance in chronic lymphocytic leukemia (CLL) with gain of the short arm of chromosome 2: role of the REL and XPO1 genes and cooperation with the deletion of the long arm of chromosome 11

Beatrice Calciolari, University of Padova, Italy

Topic: Proteomic characterization of aging germinal centers

Simona Procopio, University of Milano, Italy

Topic: Identification of novel therapeutic compounds for the treatment of infant patients with KMT2A-rearranged Acute Lymphoblastic Leukemia by drug repurposing

Edoardo Muratore, University of Bologna, Italy

Topic: Genetic and epigenetic landscape in PTPN11-mutated JMML

Joan Pera, IDIBELL, Spain

Topic: Studying the contribution of impaired DNA damage response to GATA2 deficiency pathogenesis

Antonia Zoi Kouroutzidou, Centre for Research and Technology Hellas, Greece

Topic: A novel approach to functional assessment of variants of uncertain significance from patients with myeloid malignancies

Mercedes Guerrero-Murillo, Josep Carreras Leukemia Research Institute, Spain

Topic: Characterization of leukemic relapse mechanisms to CD19-Targeted CAR T-cell therapy in pediatric B-ALL through single-cell transcriptomic sequencing

Mattia Furlan, Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia - IRCCS, Italy

Topic: Mapping the Epitranscriptome in Multiple Myeloma: Mechanisms and Therapeutic Potential

Laura Alessandrini, Vita-Salute San Raffaele University, Italy

Topic: TRACE-VEXAS: Tracing the Origin and Evolution of the UBA1-Mutant Clone

Gwan Yong Lim, Medical University of Warsaw, Poland

Topic: Mitochondrial ROS-Mediated Ferroptosis in Hematologic Malignancies

Martin Piontek, University of Veterinary Medicine, Austria

Topic: Altered ribosome-associated quality control drives resistance to targeted therapies in AML

Clelia Cortile, IRCCS Regina Elena National Cancer Institute, Italy

Topic: Dissecting 3D chromatin rewiring in Multiple Myeloma progression via enhancer hijacking underlying neo-TAD formations.

Innovation Grant

Matteo Giovanni Della Porta, Humanitas Research Hospital, Italy

Patrick Harrington, Guy's & St Thomas' NHS Foundation Trust, United Kingdom

Amin Turki, Universitätsklinikum Essen, Germany

Jan Moritz Middeke, University Hospital Dresden, Germany

Adrian Mosquera Orgueira, Instituto de Investigación Sanitaria de Santiago de Compostela, Spain

José Carda, Hospital Da Luz, Portugal

Maurilio Ponzoni, San Raffaele Scientific Institute, Italy

Topic: An AI-Based European federated Platform for Digital Pathology in Hematology: Advancing Personalized Medicine and Education Programs

Helen Papadaki, University of Crete, Greece

Bruno Antonio Cardoso, Universidade Católica Portuguesa, Portugal

Luca Malcovati, University of Pavia, Italy

Topic: Mutational spectrum and Cardiovascular Disease risk profiling in the context of Age Related Clonal Hematopoiesis and Clonal Cytopenias of Undetermined Significance (“CarD-Clone”)